Trial Profile
Prasugrel versus clopidogrel in patients with stable coronary artery disease, maintained on chronic aspirin therapy undergoing percutaneous coronary intervention.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2012
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Aspirin
- Indications Coronary artery disease; Embolism and thrombosis; Myocardial infarction
- Focus Pharmacodynamics; Therapeutic Use
- 05 Sep 2012 New trial record